Park Ha Biological Techno... (PHH)

NYSE: PHH · Real-Time Price · USD

13.42

-0.87 (-6.09%)

At close: May 02, 2025, 1:48 PM

Park Ha Biological Technology Income Statement

Financials in USD. Fiscal year is November - October.

Fiscal Year	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	315M	392M	456M	419M	495M	579M	622M	673M	645M	686M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	315M	392M	456M	419M	495M	579M	622M	673M	645M	686M
Operating Income	-180M	-225M	-296M	-477M	-421M	-365M	-313M	-193M	-248M	-305M
Interest Income	4M	-6M	n/a	24M	25M	43M	43M	41M	43M	44M
Pretax Income	-147M	-194M	-273M	-472M	-423M	-360M	-304M	-181M	-239M	-293M
Net Income	-140M	-153M	-190M	-292M	-277M	-239M	-202M	-123M	-146M	-196M
Selling & General & Admin	194M	280M	379M	433M	472M	468M	439M	421M	396M	398M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	-689M	-897M	-1.13B	-1.33B	-1.39B	-1.41B	-1.37B	-1.29B	-1.29B	-1.39B
Operating Expenses	-495M	-617M	-752M	-896M	-916M	-944M	-935M	-866M	-893M	-991M
Interest Expense	72M	74M	73M	73M	71M	73M	75M	74M	76M	82M
Selling & Marketing Expenses	19M	33M	44M	53M	59M	63M	64M	63M	63M	72M
Cost & Expenses	-495M	-617M	-752M	-896M	-916M	-944M	-935M	-866M	-893M	-991M
Income Tax Expense	-7M	-41M	-79M	-176M	-148M	-126M	-111M	-70M	-102M	-109M
Shares Outstanding (Basic)	32.67M	32.65M	32.63M	48.21M	53.34M	53.68M	53.66M	53.58M	53.57M	53.7M
Shares Outstanding (Diluted)	32.67M	32.65M	32.63M	48.21M	53.34M	53.68M	53.66M	53.58M	53.57M	53.7M
EPS (Basic)	-3.87	-3.68	-4.01	-5.54	-5.17	-4.45	-3.76	-2.2	-2.54	-3.53
EPS (Diluted)	-3.87	-3.68	-4.01	-5.54	-5.17	-4.45	-3.76	-2.2	-2.54	-3.53
EBITDA	-168M	-212M	-282M	-463M	-407M	-349M	-297M	-175M	-230M	-288M
EBIT	72M	27M	-213M	-213M	-157M	-92M	-3M	351M	804M	1.39B
Depreciation & Amortization	12M	13M	14M	14M	14M	16M	16M	18M	18M	17M